Terms: = Skin cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
25 results:
1. Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.
Jedlowski PM; DuPont JP
J Eur Acad Dermatol Venereol; 2024 May; 38(5):937-944. PubMed ID: 38071595
[TBL] [Abstract] [Full Text] [Related]
2. Quercetin increases mitochondrial proteins (VDAC and SDH) and downmodulates AXL and pim-1 tyrosine kinase receptors in NRAS melanoma cells.
Rocha-Brito KJP; Clerici SP; Cordeiro HG; Scotá Ferreira AP; Barreto Fonseca EM; Gonçalves PR; Abrantes JLF; Milani R; Massaro RR; Maria-Engler SS; Ferreira-Halder CV
Biol Chem; 2022 Feb; 403(3):293-303. PubMed ID: 34854272
[TBL] [Abstract] [Full Text] [Related]
3. Designer broad-spectrum polyimidazolium antibiotics.
Zhong W; Shi Z; Mahadevegowda SH; Liu B; Zhang K; Koh CH; Ruan L; Chen Y; Zeden MS; Pee CJE; Marimuthu K; De PP; Ng OT; Zhu Y; Chi YR; Hammond PT; Yang L; Gan YH; Pethe K; Greenberg EP; Gründling A; Chan-Park MB
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31376-31385. PubMed ID: 33229526
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced Anti-melanoma Efficacy of a pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.
Liu J; Hu Y; Guo Q; Yu X; Shao L; Zhang C
Front Immunol; 2019; 10():2721. PubMed ID: 31849942
[TBL] [Abstract] [Full Text] [Related]
5. Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities.
Coppé JP; Mori M; Pan B; Yau C; Wolf DM; Ruiz-Saenz A; Brunen D; Prahallad A; Cornelissen-Steijger P; Kemper K; Posch C; Wang C; Dreyer CA; Krijgsman O; Lee PRE; Chen Z; Peeper DS; Moasser MM; Bernards R; van 't Veer LJ
Nat Cell Biol; 2019 Jun; 21(6):778-790. PubMed ID: 31160710
[TBL] [Abstract] [Full Text] [Related]
6. pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
[TBL] [Abstract] [Full Text] [Related]
7. Post-irradiation morphoea of the breast: a case report and review of the literature.
Gonzalez-Ericsson PI; Estrada MV; Al-Rohil R; Sanders ME
Histopathology; 2018 Jan; 72(2):342-350. PubMed ID: 29110314
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
[TBL] [Abstract] [Full Text] [Related]
9. [Primary intramedullary melanoma: Case report and literature review].
Narváez-Martínez Y; de la Ossa N; López-Martos R; Cohn-Reinoso C; Castellví-Juan M; Martin-Ferrer S
Neurocirugia (Astur); 2017; 28(4):190-196. PubMed ID: 28237771
[TBL] [Abstract] [Full Text] [Related]
10. pim kinases as therapeutic targets against advanced melanoma.
Shannan B; Watters A; Chen Q; Mollin S; Dörr M; Meggers E; Xu X; Gimotty PA; Perego M; Li L; Benci J; Krepler C; Brafford P; Zhang J; Wei Z; Zhang G; Liu Q; Yin X; Nathanson KL; Herlyn M; Vultur A
Oncotarget; 2016 Aug; 7(34):54897-54912. PubMed ID: 27448973
[TBL] [Abstract] [Full Text] [Related]
11. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, pim1, in melanoma.
Rang Z; Yang G; Wang YW; Cui F
Biochem Biophys Res Commun; 2016 May; 474(2):315-320. PubMed ID: 27107696
[TBL] [Abstract] [Full Text] [Related]
12. A Novel Cinnamon-Related Natural Product with pim-1 Inhibitory Activity Inhibits Leukemia and skin cancer.
Kim JE; Son JE; Jeong H; Joon Kim D; Seo SK; Lee E; Lim TG; Kim JR; Chen H; Bode AM; Lee KW; Dong Z
Cancer Res; 2015 Jul; 75(13):2716-2728. PubMed ID: 25948588
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome.
van der Fits L; Out-Luiting JJ; Tensen CP; Zoutman WH; Vermeer MH
J Invest Dermatol; 2014 Oct; 134(10):2639-2647. PubMed ID: 24756111
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract] [Full Text] [Related]
15. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.
Wozniak MB; Villuendas R; Bischoff JR; Aparicio CB; Martínez Leal JF; de La Cueva P; Rodriguez ME; Herreros B; Martin-Perez D; Longo MI; Herrera M; Piris MA; Ortiz-Romero PL
Haematologica; 2010 Apr; 95(4):613-21. PubMed ID: 20133897
[TBL] [Abstract] [Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
[TBL] [Abstract] [Full Text] [Related]
17. "Composite graft": a simple option for nasal lining.
Cordova A; Di Lorenzo S; Moschella F
Int J Dermatol; 2007 Apr; 46(4):417-21. PubMed ID: 17442089
[TBL] [Abstract] [Full Text] [Related]
18. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract] [Full Text] [Related]
19. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract] [Full Text] [Related]
20. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
Tsuda H; Fukamachi K; Ohshima Y; Ueda S; Matsuoka Y; Hamaguchi T; Ohnishi T; Takasuka N; Naito A
Cancer Sci; 2005 Jun; 96(6):309-16. PubMed ID: 15958052
[TBL] [Abstract] [Full Text] [Related]
[Next]
